Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Captopril or conventional therapy in hypertensive type II diabetics. Three-year analysis.

Lacourcière Y, Nadeau A, Poirier L, Tancrède G.

Hypertension. 1993 Jun;21(6 Pt 1):786-94.

2.
3.

Placebo-controlled comparison of captopril, metoprolol, and hydrochlorothiazide therapy in non-insulin-dependent diabetic patients with primary hypertension.

Gall MA, Rossing P, Skøtt P, Hommel E, Mathiesen ER, Gerdes LU, Lauritzen M, Vølund A, Faergeman O, Beck-Nielsen H, et al.

Am J Hypertens. 1992 May;5(5 Pt 1):257-65.

PMID:
1581012
4.

Renoprotective effect of diltiazem in hypertensive type 2 diabetic patients with persistent microalbuminuria despite ACE inhibitor treatment.

Pérez-Maraver M, Carrera MJ, Micaló T, Sahun M, Vinzia C, Soler J, Montanya E.

Diabetes Res Clin Pract. 2005 Oct;70(1):13-9. Epub 2005 Apr 15.

PMID:
16126118
5.

Systemic and renal effects of chronic angiotensin converting enzyme inhibition with captopril in hypertensive diabetic patients.

Stornello M, Valvo EV, Vasques E, Leone S, Scapellato L.

J Hypertens Suppl. 1989 Sep;7(7):S65-7.

PMID:
2693660
7.

[The effect of blood pressure-reducing therapy with captopril on tubular marker excretion in type-1 diabetics with nephropathy].

Ratzmann KP, Raskovic M, Schimke E.

Dtsch Med Wochenschr. 1994 Jun 3;119(22):796-800. German.

PMID:
8205941
8.
10.
11.
12.

Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.

Chan JC, Ko GT, Leung DH, Cheung RC, Cheung MY, So WY, Swaminathan R, Nicholls MG, Critchley JA, Cockram CS.

Kidney Int. 2000 Feb;57(2):590-600.

14.

Comparative effects of indapamide and captopril on blood pressure and albumin excretion rate in diabetic microalbuminuria.

Donnelly R, Molyneaux LM, Willey KA, Yue DK.

Am J Cardiol. 1996 Feb 22;77(6):26B-30B. Review.

PMID:
8848991
15.

Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study.

Bakris GL, Toto RD, McCullough PA, Rocha R, Purkayastha D, Davis P; GUARD (Gauging Albuminuria Reduction With Lotrel in Diabetic Patients With Hypertension) Study Investigators.

Kidney Int. 2008 Jun;73(11):1303-9. doi: 10.1038/ki.2008.102. Epub 2008 Mar 19.

16.

Rilmenidine in the hypertensive type-2 diabetic: a controlled pilot study versus captopril.

Bauduceau B, Mayaudon H, Dupuy O.

J Cardiovasc Risk. 2000 Feb;7(1):57-61.

PMID:
10785875
18.

Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy.

Lacourcière Y, Bélanger A, Godin C, Hallé JP, Ross S, Wright N, Marion J.

Kidney Int. 2000 Aug;58(2):762-9.

19.

Captopril does not alter metabolic control in elderly hypertensive diabetics during secondary failure.

De Mattia G, Laurenti O, Tullo G, Ziantoni R, Ferri C, Ventura C, Balsano F.

J Hypertens Suppl. 1988 Nov;6(1):S113-5.

PMID:
3063785
20.

The effect of captopril on renal hemodynamics in hypertensive patients.

Duchin KL, Willard DA.

J Clin Pharmacol. 1984 Aug-Sep;24(8-9):351-9.

PMID:
6384279

Supplemental Content

Support Center